Screener
KRMA vs GNOM
Global X Conscious Companies ETF vs Global X Genomics & Biotechnology ETF
Key differences
- KRMA costs 0.07% less per year.
- Over the last 3 years, KRMA has delivered higher annualized returns.
Side-by-side comparison
| KRMA | GNOM | |
|---|---|---|
| Annual cost (TER) | 0.43% | 0.50% |
| Fund size (AUM) | $116M | $51M |
| Since | 2016 | 2019 |
| Dividend yield | 2.46% | 1.38% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +26.4% | +53.6% |
| CAGR 3Y | +19.1% | -2.6% |
| CAGR 5Y | +10.7% | -10.5% |
| Sharpe 3Y | 1.01 | -0.06 |
| Volatility 1Y | 12.35% | 26.15% |
| Max drawdown | -36.16% | -75.00% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to KRMA and GNOM
Explore further